Institutional investors purchased a net $5.4 million shares of OPK during the quarter ended June 2015. This may signal that the smart money is gaining interest in this company as the 26.99% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CREDIT SUISSE AG Bought 8.4 Thousand shares of OPKO Health Inc
STATE STREET GLOBAL ADVISORS LTD... Bought 112.00 shares of OPKO Health Inc
BLACKROCK INVESTMENT MANAGEMENT ... Bought 81.00 shares of OPKO Health Inc